These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 6088761

  • 1. Interaction of opiate receptor binding sites and guanine nucleotide regulatory sites: selective protection from N-ethylmaleimide.
    Childers SR.
    J Pharmacol Exp Ther; 1984 Sep; 230(3):684-91. PubMed ID: 6088761
    [Abstract] [Full Text] [Related]

  • 2. pH selectivity of N-ethylmaleimide reactions with opiate receptor complexes in rat brain membranes.
    Childers SR, Jackson JL.
    J Neurochem; 1984 Oct; 43(4):1163-70. PubMed ID: 6088695
    [Abstract] [Full Text] [Related]

  • 3. Cation and guanine nucleotide effects on ligand binding properties of mu and delta opioid receptors in rat brain membranes.
    Benyhe S, Szücs M, Varga E, Simon J, Borsodi A, Wollemann M.
    Acta Biochim Biophys Hung; 1989 Oct; 24(1-2):69-81. PubMed ID: 2558475
    [Abstract] [Full Text] [Related]

  • 4. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
    Stratford CA, Tan GL, Hamblin MW, Ciaranello RD.
    Mol Pharmacol; 1988 Oct; 34(4):527-36. PubMed ID: 3139989
    [Abstract] [Full Text] [Related]

  • 5. Selective alterations in guanine nucleotide regulation of opiate receptor binding and coupling with adenylate cyclase.
    Childers SR, Lambert SM, La Riviere G.
    Life Sci; 1983 Oct; 33 Suppl 1():215-8. PubMed ID: 6319864
    [Abstract] [Full Text] [Related]

  • 6. Muscarinic receptors in porcine caudate nucleus. II. Different effects of N-ethylmaleimide on [3H]cis-methyldioxolane binding to heat-labile (guanyl nucleotide-sensitive) sites and heat-stable (guanyl nucleotide-insensitive) sites.
    Nukada T, Haga T, Ichiyama A.
    Mol Pharmacol; 1983 Nov; 24(3):374-9. PubMed ID: 6633504
    [Abstract] [Full Text] [Related]

  • 7. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T, Zukin RS.
    Mol Pharmacol; 1983 Sep; 24(2):203-12. PubMed ID: 6310362
    [Abstract] [Full Text] [Related]

  • 8. Differential roles of high and low affinity guanosine 5'-triphosphate binding sites in the regulation of follicle-stimulating hormone binding to receptor and signal transduction in bovine calf testis membranes.
    Zhang SB, Dattatreyamurty B, Reichert LE.
    Endocrinology; 1991 Jan; 128(1):295-302. PubMed ID: 1898882
    [Abstract] [Full Text] [Related]

  • 9. Microsomal opiate receptors: characterization of smooth microsomal and synaptic membrane opiate receptors.
    Roth BL, Coscia CJ.
    J Neurochem; 1984 Jun; 42(6):1677-84. PubMed ID: 6327910
    [Abstract] [Full Text] [Related]

  • 10. Regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide.
    Ehlert FJ, Roeske WR, Yamamura HI.
    J Supramol Struct; 1980 Jun; 14(2):149-62. PubMed ID: 7230804
    [Abstract] [Full Text] [Related]

  • 11. Spontaneous coupling of the beta-adrenergic receptor to Ns in mammalian cardiac membranes.
    Nerme V, Severne Y, Abrahamsson T, Vauquelin G.
    Mol Pharmacol; 1986 Jul; 30(1):1-5. PubMed ID: 3014306
    [Abstract] [Full Text] [Related]

  • 12. Modulation of muscarinic cholinergic receptor affinity for antagonists in rat heart.
    Martin MW, Smith MM, Harden TK.
    J Pharmacol Exp Ther; 1984 Aug; 230(2):424-30. PubMed ID: 6379149
    [Abstract] [Full Text] [Related]

  • 13. Sulfhydryl groups on opioid receptors revisited. Evidence for two sulfhydryl groups at or near the active site of the mu opioid receptor.
    Ofri D, Simon EJ.
    Receptor; 1992 Aug; 2(2):109-19. PubMed ID: 1335327
    [Abstract] [Full Text] [Related]

  • 14. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL, Recht LD, Pasternak GW.
    Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
    [Abstract] [Full Text] [Related]

  • 15. Anatomical distribution of sodium-dependent [(3)H]naloxone binding sites in rat brain.
    Sim-Selley LJ, Xiao R, Childers SR.
    Synapse; 2000 Mar 15; 35(4):256-64. PubMed ID: 10657035
    [Abstract] [Full Text] [Related]

  • 16. Opioid agonist binding affinity is increased by magnesium in the presence of guanosine diphosphate but decreased by magnesium in the presence of guanyl-5'-yl imidodiphosphate.
    Wong CS, Su YF, Watkins WD, Chang KJ.
    J Pharmacol Exp Ther; 1994 Feb 15; 268(2):653-61. PubMed ID: 8113975
    [Abstract] [Full Text] [Related]

  • 17. [A kinetic model of the interaction of stable GTP analogs with a system of opioid receptors].
    Skliankina OA, Kurochkin IN, Keldysh PL, Zaĭtsev SV, Varfolomeev SD.
    Biokhimiia; 1988 Feb 15; 53(2):205-13. PubMed ID: 2835995
    [Abstract] [Full Text] [Related]

  • 18. Modification of guanine nucleotide-regulatory components in brain membranes. II. Relationship of guanosine 5'-triphosphate effects on opiate receptor binding and coupling receptors with adenylate cyclase.
    Childers SR, LaRiviere G.
    J Neurosci; 1984 Nov 15; 4(11):2764-71. PubMed ID: 6094742
    [Abstract] [Full Text] [Related]

  • 19. Multiple affinity binding states of the sigma receptor: effect of GTP-binding protein-modifying agents.
    Itzhak Y.
    Mol Pharmacol; 1989 Oct 15; 36(4):512-7. PubMed ID: 2554109
    [Abstract] [Full Text] [Related]

  • 20. Interaction of a radiolabeled agonist with cardiac muscarinic cholinergic receptors.
    Harden TK, Meeker RB, Martin MW.
    J Pharmacol Exp Ther; 1983 Dec 15; 227(3):570-7. PubMed ID: 6317839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.